![Thomas Kassberg](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 6 M $ al 31/05/2026
Thomas Richard Kassberg was the founder of Plexxikon, Inc., founded in 2000, where the title held was Vice President-Business & Corporate Development from 2000 to 2004.
The current job is Director at Passage Bio, Inc. starting in 2024.
Former jobs include Senior Director-Corporate Licensing at Pharmacia, Inc., Principal at Bristol Myers Squibb Co., SVP-Business Development & Corporate Licensing at Sugen, Inc. from 1995 to 1999, SVP-Corporate Development & Commercial Operations at InterMune, Inc. from 2004 to 2007, Chief Business Officer at Melinta Subsidiary Corp., Vice President-Business Development at Corium LLC (Massachusetts) from 2010 to 2011, Chief Business Officer & Executive Vice President at Ultragenyx Pharmaceutical, Inc. from 2016 to 2025, President at Dimension Therapeutics, Inc., and Senior Vice President-Corporate Development at Proteolix, Inc. from 2008 to 2009.
Education includes an undergraduate degree from Gustavus Adolphus College conferred in 1982 and an MBA from Kellogg School of Management.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 03/03/2025 | 264.730 ( 0,27 % ) | 6 M $ | 31/05/2026 | |
PASSAGE BIO, INC. -.--% | 19/05/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| PASSAGE BIO, INC. | Director/Miembro de la Junta | 10/09/2024 |
| Empresas | Cargo | Fin |
|---|---|---|
| ULTRAGENYX PHARMACEUTICAL INC. | Corporate Officer/Principal | 22/09/2025 |
| CORIUM INTERNATIONAL INC | Corporate Officer/Principal | 01/10/2011 |
Proteolix, Inc.
 Proteolix, Inc. Pharmaceuticals: MajorHealth Technology Manufactures bio-pharmaceutical related products | Corporate Officer/Principal | 01/02/2009 |
| INTERMUNE INC | Corporate Officer/Principal | 03/07/2007 |
Plexxikon, Inc.
 Plexxikon, Inc. Miscellaneous Commercial ServicesCommercial Services Provides clinical and medical drug discovery and development services | Fundador | 01/07/2004 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 13 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Sugen, Inc.
 Sugen, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs and related pharmaceutical products | Health Technology |
InterMune, Inc.
 InterMune, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that researches and develops therapies in pulmonology & orphan fibrotic diseases | Health Technology |
Plexxikon, Inc.
Plexxikon, Inc. Miscellaneous Commercial ServicesCommercial Services Provides clinical and medical drug discovery and development services | Commercial Services |
Ultragenyx Pharmaceutical, Inc.
 Ultragenyx Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel products for the treatment of serious rare and ultra-rare genetic diseases | Health Technology |
Gustavus Adolphus College
 Gustavus Adolphus College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Melinta Subsidiary Corp.
 Melinta Subsidiary Corp. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products for the treatment of life-threatening infections | Health Technology |
Proteolix, Inc.
Proteolix, Inc. Pharmaceuticals: MajorHealth Technology Manufactures bio-pharmaceutical related products | Health Technology |
Corium International, Inc.
 Corium International, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of novel neuroscience therapies | Health Technology |
Pharmacia, Inc. | |
Dimension Therapeutics, Inc.
 Dimension Therapeutics, Inc. BiotechnologyHealth Technology Develops novel treatments for rare diseases | Health Technology |
Kellogg School of Management
 Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Passage Bio, Inc.
 Passage Bio, Inc. BiotechnologyHealth Technology Develops therapies for the treatment of monogenic central nervous system disorders | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
